Clinical Trial Update: A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual Migraine [Phase 3]

View source ↗

Summary

A Phase 3 controlled trial evaluated frovatriptan for preventing menstrual migraine; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• FROVATRIPTAN (FROVATRIPTAN SUCCINATE)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Migraine | Phase 3 | Status: COMPLETED